Published on
July 13, 2026
- 14:55 GMT
AI-enabled drug discovery collaboration with VERAXA biotech to support growing BiTAC® pipeline
KRAKOW, POLAND, July 13, 2026 /EINPresswire.com/ -- Ardigen’s AI and computational biology capabilities will strengthen VERAXA’s in-house AI efforts to optimize cancer target pair selection for conditionally active T cell engagers and antibody-drug …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
